Literature DB >> 10541241

Expression of vascular permeability factor in craniopharyngioma.

J Vaquero1, M Zurita, S de Oya, S Coca, C Morales, C Salas.   

Abstract

OBJECT: The expression of vascular endothelial growth/permeability factor (VEG/PF) has recently been correlated with the presence of tumor-associated cysts in some intracranial tumors. The purpose of this study was to evaluate a possible relationship between the presence of VEG/PF and the formation of cysts in craniopharyngiomas.
METHODS: The expression of VEG/PF was studied in histological specimens from a series of 12 craniopharyngiomas. In this series, the tumors were classified as presenting a mainly solid pattern with small macroscopic cysts (four patients) or a mainly cystic pattern (eight patients). The mainly solid tumors containing small macroscopic cysts showed little or no VEG/PF positivity, which was mainly present in tumor cells surrounding cysts. Nevertheless, mainly cystic craniopharyngiomas showed a moderate or high degree of VEG/PF positivity in tumor cells.
CONCLUSIONS: These findings indicate that the predominance of a cystic or solid macroscopic appearance of craniopharyngiomas may be influenced by the degree of VEG/PF expression within the tumor cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541241     DOI: 10.3171/jns.1999.91.5.0831

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Angiogenesis in craniopharyngiomas: Microvascular density and tissue expression of the vascular endothelial growth factor (VEGF) and endostatin.

Authors:  Cristina M Dallago; Miriam C Oliveira; Ligia M Barbosa-Coutinho; Nelson P Ferreira
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Angiogenesis and the growth potential of craniopharyngiomas.

Authors:  Sergio Vidal; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

3.  The role of inflammation in the genesis of the cystic component of craniopharyngiomas.

Authors:  Benedetta Ludovica Pettorini; Rosanna Inzitari; Luca Massimi; Gianpiero Tamburrini; Massimo Caldarelli; Chiara Fanali; Tiziana Cabras; Irene Messana; Massimo Castagnola; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2010-07-29       Impact factor: 1.475

4.  Microsurgical resection of foramen magnum meningioma: multi-institutional retrospective case series and proposed surgical risk scoring system.

Authors:  Nida Fatima; John H Shin; William T Curry; Steven D Chang; Antonio Meola
Journal:  J Neurooncol       Date:  2021-05-10       Impact factor: 4.130

5.  Transplantation of human oligodendrocyte progenitor cells in an animal model of diffuse traumatic axonal injury: survival and differentiation.

Authors:  Leyan Xu; Jiwon Ryu; Hakim Hiel; Adarsh Menon; Ayushi Aggarwal; Elizabeth Rha; Vasiliki Mahairaki; Brian J Cummings; Vassilis E Koliatsos
Journal:  Stem Cell Res Ther       Date:  2015-05-14       Impact factor: 6.832

6.  Ki67 as a prognostic factor of craniopharyngioma's recurrence in paediatric population.

Authors:  Elżbieta Moszczyńska; Monika Prokop-Piotrkowska; Agnieszka Bogusz-Wójcik; Wiesława Grajkowska; Sylwia Szymańska; Mieczysław Szalecki
Journal:  Childs Nerv Syst       Date:  2020-02-07       Impact factor: 1.475

7.  Impact of neutrophil-lymphocyte ratio on long-term outcome in patients with craniopharyngioma.

Authors:  Jing Zhang; Min He; Zhiyong Liu; Yanlin Song; Yuelong Wang; Ruichao Liang; Hongxu Chen; Jianguo Xu
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.